About: Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 04 December 2018

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в грудні 2018 (uk) artículu científicu espublizáu n'avientu de 2018 (ast) scientific article published on 04 December 2018 (en)
publication date	wds:Q90320705-D086972C-0AEA-428E-820F-B625A3AB0612
publication date	2018-12-04 00:00:00Z (xsd:dateTime)
author name string	wds:Q90320705-0D1A8344-38E5-4E7F-92D8-A1DAA035EAA7 wds:Q90320705-17E9598A-428B-45AC-9FE4-9D9B283ACAAC wds:Q90320705-4350DD1F-AD6A-4E71-9726-C74E3A4ABB8A wds:Q90320705-505B6545-7527-4864-883A-49057D8DAA12 wds:Q90320705-56562B7C-CA16-44D2-9053-F1218D957D5F wds:Q90320705-56A0003A-38B7-473E-8FBD-8857815B6F89 wds:Q90320705-5D30B6F4-5342-48FF-BD56-0BBF6A20CBE3 wds:Q90320705-65F00F91-9FC8-478F-B8BE-C8840740BD62 wds:Q90320705-6A228340-D063-4FFB-8567-C3C5DE176408 wds:Q90320705-7BA3DECB-21BE-4CDB-BE65-A04FB48D9B84 wds:Q90320705-8BAEE28F-EFAE-4C41-9181-0EE141FACBC8 wds:Q90320705-92DB82FD-5AEE-4E7C-BBAA-8E16FA4EC84E wds:Q90320705-C7F6B6E3-9B6B-43B5-A84B-4FC52AC47328 wds:Q90320705-DE39F548-8A64-4B04-B631-614306CDF88B wds:Q90320705-EB91C661-241F-438E-B540-0FA7F1DFA25F
author name string	Teresa Macarulla Fernando Rivera Manuel Hidalgo Ruth Vera Rafael López Carmen Guillén-Ponce Javier Sastre Sofia Perea Joaquina Martínez-Galán Margarita Reboredo Roberto Díaz Beveridge Roberto Pazo-Cid Andrés Muñoz Martin Immaculada Ales José Martín Valadés
rdfs:label	Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2 (en) Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2 (nl)
skos:prefLabel	Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2 (en) Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2 (nl)
name	Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2 (en) Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2 (nl)
author	wds:Q90320705-BAE8B507-7A10-4F00-BA38-9EFB4C7EC904
author	Adelaida Lacasta
title	wds:Q90320705-982F5503-B742-47B6-96F0-FCA2CFA6C1F2
title	Phase I/II Trial to Evaluate the Efficacy and Safety of Nanoparticle Albumin-Bound Paclitaxel in Combination With Gemcitabine in Patients With Pancreatic Cancer and an ECOG Performance Status of 2 (en)
page(s)	wds:Q90320705-355C4165-69A4-4FD4-9B1D-15C2FDD55BC9
page(s)	230-238
instance of	wds:Q90320705-444007DF-435F-4CB9-80BD-9845FD1F232C
instance of	scholarly article
main subject	wds:Q90320705-44EDA383-63B4-4253-8538-2E78D3EBF901 wds:Q90320705-82471014-A12C-49C6-A596-E8FEDE908040 wds:Q90320705-8740B31F-81B4-459A-BCB7-E219ECF3171D wds:Q90320705-A833AF3A-7AC5-4AA4-87BC-5AEABC1DA28B
main subject	pancreatic cancer phase I clinical trial wd:Q423762 nanoparticle
PubMed ID	wds:Q90320705-E815B4BD-0F89-44BC-BA9A-4A54112A1BEB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/30523758
PubMed ID	30523758
published in	wds:Q90320705-19D643AB-2147-414C-B5FE-408A380FAEBE
published in	Journal of Clinical Oncology
issue	wds:Q90320705-B423DFD8-EFDE-4E5A-B3DC-3ACCF69D8D44
volume	wds:Q90320705-B98B6A25-E9DB-4E7A-B0C3-C253D68469B0
issue	3
volume	37
DOI	wds:Q90320705-AE9A9314-B6C0-4442-9A29-76ADDABF3840
DOI	http://dx.doi.org/10.1200/JCO.18.00089
DOI	10.1200/JCO.18.00089
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q90320705
is cites work of	Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial-Mesenchymal Transition: Enhanced Efficacy when Combined with Gemcitabine Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine versus FOLFIRINOX in advanced pancreatic cancer: a systematic review. First line nab-paclitaxel plus gemcitabine in elderly metastatic pancreatic patients: a good choice beyond age Characteristics and survival of older patients with metastatic pancreatic cancer: a retrospective analysis of the AC Camargo Cancer Center experience
is cites work of	wds:Q92570492-F79D8261-462E-408D-BB9E-5709C7B22845 wds:Q90446343-2A3509F8-5B61-4AF4-BEAF-DD6167C878F1 wds:Q64949932-84099AAC-ABB2-4E6B-B46E-F6033C6D84A4 wds:Q96029327-A3B3060F-AE3D-449B-B82D-897AB9FCCF4F wds:Q90643895-CF6E6A39-E714-42B9-9D47-5574718D9185 wds:Q90169589-C88FE3B6-EA00-4453-A28D-DC6F069DE41D

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 196 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software